Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN7 | P35236 | 5/20 | 0.70 |
| ▸ | TERT | O14746 | 3/20 | 0.70 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.70 |
| ▸ | PPARG | P37231 | 3/20 | 0.70 |
| ▸ | PPARD | Q03181 | 3/20 | 0.70 |
| ▸ | PPARA | Q07869 | 3/20 | 0.70 |
| ▸ | HMGCR | P04035 | 3/20 | 0.70 |
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | BLM | P54132 | 2/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.70 |
| ▸ | FABP4 | P15090 | 2/20 | 0.70 |
| ▸ | F7 | P08709 | 2/20 | 0.70 |
| ▸ | F3 | P13726 | 2/20 | 0.70 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.70 |
| ▸ | GMNN | O75496 | 1/20 | 0.70 |
| ▸ | USP2 | O75604 | 1/20 | 0.70 |
| ▸ | LMNA | P02545 | 1/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.70 |
| ▸ | POLB | P06746 | 1/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL41374 | 1.00 | PTPN7 (0.70) | PTPN7TERTPTPN1PPARGPPARD | |
| SCHEMBL1371369 | 1.00 | PTPN7 (0.70) | PTPN7TERTPTPN1PPARGPPARD | |
| SCHEMBL1738166 | 1.00 | PTPN7 (0.70) | PTPN7TERTPTPN1PPARGPPARD | |
| SCHEMBL27039218 | 1.00 | PTPN7 (0.70) | PTPN7TERTPTPN1PPARGPPARD | |
| SCHEMBL1374586 | 1.00 | PTPN7 (0.70) | PTPN7TERTPTPN1PPARGPPARD | |
| SCHEMBL269349 | 1.00 | PTPN7 (0.70) | PTPN7TERTPTPN1PPARGPPARD | |
| SCHEMBL1374589 | 1.00 | PTPN7 (0.70) | PTPN7TERTPTPN1PPARGPPARD | |
| SCHEMBL10918369 | 0.95 | PTPN7 (0.67) | PTPN7TERTPTPN1PPARGPPARD | |
| SCHEMBL7594655 | 0.94 | PPARG (0.71) | PTPN7TERTPTPN1PPARGPPARD | |
| SCHEMBL7589866 | 0.94 | PPARG (0.71) | PTPN7TERTPTPN1PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140099354-A1 | BIOPASSIVATING MEMBRANE STABILIZATION BY MEANS OF NITROCARBOXYLIC ACID-CONTAINING PHOSPHOLIPIDS IN PREPARATIONS AND COATINGS | Dietz, Ulrich (DE) | 2014-04-10 | — | — | US | claimed |
| US-20130039956-A1 | USE OF NITROCARBOXYLIC ACIDS FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF AGGRESSIVE HEALING PATTERNS | Dietz, Ulrich (DE) | 2013-02-14 | — | — | US | claimed |
| EP-2547322-A2 | USE OF NITROCARBOXYLIC ACIDS FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF AGGRESSIVE HEALING PATTERNS | Dietz, Ulrich (DE) | 2013-01-23 | — | — | EP | claimed |
| WO-2011113507-A2 | USE OF NITROCARBOXYLIC ACIDS FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF AGGRESSIVE HEALING PATTERNS | DIETZ ULRICH (DE) | 2011-09-22 | — | — | WO | claimed |
| EP-1666092-A2 | Drug combination comprising a fatty acid and a uridine compound. | Trommsdorff GmbH & Co.KG Arzneimittel (DE) | 2006-06-07 | — | — | EP | claimed |
| US-20050043394-A1 | Pharmaceutically active uridine esters | TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL | 2005-02-24 | — | — | US | claimed |
| JP-2004531543-A | — | — | 2004-10-14 | — | — | JP | claimed |
| US-20040121979-A1 | Pharmaceutically active uridine esters | TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2004-06-24 | — | — | US | claimed |
| EP-1390378-A1 | PHARMACEUTICALLY ACTIVE URIDINE ESTERS | Trommsdorff GmbH & Co. KG Arzneimittel (DE) | 2004-02-25 | — | — | EP | claimed |
| WO-2002088159-A1 | PHARMACEUTICALLY ACTIVE URIDINE ESTERS | TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2002-11-07 | — | — | WO | claimed |
| US-11952581-B2 | Process for the production of polyunsaturated fatty acids in transgenic organisms | BASF PLANT SCIENCE GMBH (DE) | 2024-04-09 | — | — | US | disclosed |
| EP-4219670-A2 | Method for producing polyunsaturated fatty acids in transgenic organisms | BASF Plant Science GmbH (DE) | 2023-08-02 | — | — | EP | disclosed |
| US-20220162629-A1 | Process for the Production of Polyunsaturated Fatty Acids in Transgenic Organisms | BASF PLANT SCIENCE GMBH (DE) | 2022-05-26 | — | — | US | disclosed |
| US-20220056423-A1 | PROCESSES FOR PRODUCING POLYUNSATURATED FATTY ACIDS IN TRANSGENIC ORGANISMS | BASF PLANT SCIENCE GMBH (DE) | 2022-02-24 | — | — | US | disclosed |
| US-11180769-B2 | Method for the production of multiple-unsaturated fatty acids in transgenic organisms | BASF PLANT SCIENCE GMBH (DE) | 2021-11-23 | — | — | US | disclosed |
| US-20050043394-A1 | Pharmaceutically active uridine esters | TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL | 2005-02-24 | — | — | US | disclosed |
| US-20050043269-A1 | Pharmaceutically active uridine esters | TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL | 2005-02-24 | — | — | US | disclosed |
| US-20040121979-A1 | Pharmaceutically active uridine esters | TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2004-06-24 | — | — | US | disclosed |
| EP-1390378-A1 | PHARMACEUTICALLY ACTIVE URIDINE ESTERS | Trommsdorff GmbH & Co. KG Arzneimittel (DE) | 2004-02-25 | — | — | EP | disclosed |
| WO-2002088159-A1 | PHARMACEUTICALLY ACTIVE URIDINE ESTERS | TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2002-11-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050043394-A1 | Pharmaceutically active uridine esters | UMPS, UGDH, FFAR3 | PTPN7 4387/4885TERT 1841/4885PTPN1 4586/4885 |
| US-20220056423-A1 | PROCESSES FOR PRODUCING POLYUNSATURATED FATTY ACIDS IN TRANSGENIC ORGANISMS | ELOVL3, ELOVL1, ELOVL5 | PTPN7 4002/4885TERT 1259/4885PTPN1 3940/4885 |
| US-20040121979-A1 | Pharmaceutically active uridine esters | UMPS, UGDH, FFAR1 | PTPN7 4353/4885TERT 1854/4885PTPN1 4416/4885 |
| US-20130039956-A1 | USE OF NITROCARBOXYLIC ACIDS FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF AGGRESSIVE HEALING PATTERNS | NOS1, NOS2, NOS3 | PTPN7 1190/4885TERT 3447/4885PTPN1 772/4885 |
| US-20140099354-A1 | BIOPASSIVATING MEMBRANE STABILIZATION BY MEANS OF NITROCARBOXYLIC ACID-CONTAINING PHOSPHOLIPIDS IN PREPARATIONS AND COATINGS | PHOSPHO1, PTDSS1, LIPG | PTPN7 1369/4885TERT 4365/4885PTPN1 1059/4885 |
| US-20050043269-A1 | Pharmaceutically active uridine esters | UMPS, UGDH, FFAR3 | PTPN7 4387/4885TERT 1841/4885PTPN1 4586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.